The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone

Background: There are limited data regarding the efficacy of addition of entecavir (ETV) or tenofovir disoproxil fumarate (TDF) to Peg-IFNα-2b in HBeAg positive chronic hepatitis B (CHB) patients without early response to Peg-IFNα-2b. In this study, we aimed to evaluate the efficacy of ETV and TDF i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Sheng, Fu, Ya, Wu, Wennan, Chen, Tianbin, Chen, Ningdai, Xun, Zhen, Liu, Can, Ou, Qishui, Zeng, Yongbin, Huang, Huanhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330670/
https://www.ncbi.nlm.nih.gov/pubmed/32624702
http://dx.doi.org/10.7150/ijms.45658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330670/
https://www.ncbi.nlm.nih.gov/pubmed/32624702
http://dx.doi.org/10.7150/ijms.45658

Ejemplares similares